Dr Reddy's Q2 profit up 69 per cent at Rs 690 crore
Oct 31 2013 , New Delhi
The company had posted a profit of Rs 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs 3,357.45 crore from Rs 2,880.85 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing. Revenue from the global generics segment grew 32 per cent to Rs 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
Shares of Dr Reddy's Laboratories were down 2.52 per cent at Rs 2,459.20 on the BSE in late afternoon trade.